dr. reddy's labs glp-1 receptor agonist medications Laboratories Launches Obeda: A Breakthrough in Type 2 Diabetes Treatment, ETPharma Evolution of GLP‐1 Receptor Agonists

GLP-1 medications interact with certain drugs, supplements, and substances that may reduce efficacy or increase side effects

Delve into the perspectives of employers and health plans on obesity, GLP-1 coverage rates, and concerns about off-label use.

NBC News' Berkeley Lovelace Jr

New research is taking a closer look at what can happen when people stop taking GLP-1 medications for a long period of time.

An effective treatment might require either utilization of multiple drugs which target the individual pathological processes which underlie the neurodegenerative disease or the use of a single agent which could influence multiple pathological processes